Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KAINOS Laboratories's Other Operating Expense for the
six
months ended in Mar. 2026 was 円912 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,845 Mil.
KAINOS Laboratories's quarterly Other Operating Expense
declined
from Mar. 2025 (円938 Mil) to Sep. 2025 (円932 Mil) and
declined
from Sep. 2025 (円932 Mil) to Mar. 2026 (円912 Mil).
KAINOS Laboratories's annual Other Operating Expense
increased
from Mar. 2024 (円1,153 Mil) to Mar. 2025 (円1,204 Mil) but then
declined
from Mar. 2025 (円1,204 Mil) to Mar. 2026 (円1,181 Mil).
KAINOS Laboratories Other Operating Expense Related Terms
KAINOS Laboratories Other Operating Expense Historical Data
* Premium members only.
The historical data trend for KAINOS Laboratories's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円1,845 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円1,845 Mil mean?
KAINOS Laboratories (TSE:4556) has a Other Operating Expense of 円1,845 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on KAINOS Laboratories and its competitors.
Is KAINOS Laboratories' Other Operating Expense too high?
KAINOS Laboratories' current Other Operating Expense is 円1,845 Mil. Overall, KAINOS Laboratories has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' Other Operating Expense compare to ISRG and BDX?
KAINOS Laboratories' Other Operating Expense of 円1,845 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on KAINOS Laboratories and its competitors. KAINOS Laboratories's current Other Operating Expense is 円1,845 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,285.67, compared to a current price of 円2,268.00 — trading 76.4% above its estimated fair value. The current Other Operating Expense is 円1,845 Mil. KAINOS Laboratories' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current Other Operating Expense is 円1,845 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?
Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued.
The current stock price of 円2,268.00 is trading 76.4% above its estimated GF Value™ of 円1,285.67.
GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.
Key valuation signals for TSE:4556:
Other Operating Expense: 円1,845 Mil
GF Value™: 円1,285.67 vs. price of 円2,268.00 (76.4% above fair value)
No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
40GF Score
Get the complete analysis for TSE:4556
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4556 has been successfully added to your 
